Albert David Reports Significant Financial Declines in May 2025 Results

May 13 2025 09:02 PM IST
share
Share Via
Albert David, a microcap pharmaceutical company, reported its financial results for the quarter ending March 2025, revealing significant challenges. Key metrics showed a decline in profit before tax, net sales, and operating profit, with the lowest sales figures recorded in five quarters and a notable drop in earnings per share.
Albert David, a microcap company in the Pharmaceuticals & Drugs industry, has recently reported its financial results for the quarter ending March 2025. The results, declared on May 13, 2025, indicate a challenging period for the company, with notable shifts in its financial metrics.

The evaluation changes reflect a score adjustment to -10 from -18 over the past three months. This revision highlights the ongoing difficulties faced by Albert David. The Profit Before Tax less Other Income (PBT) for the quarter stands at Rs -6.70 crore, marking a significant decline of 187.35% year on year. Additionally, net sales have also shown a downward trend, recorded at Rs 74.89 crore, which is a 15.91% decrease compared to the previous year and represents the lowest sales figure in the last five quarters.

The operating profit has similarly reached its lowest point at Rs -4.75 crore, with an operating profit margin of -6.34%, indicating a decline in the company's operational efficiency. Furthermore, the earnings per share (EPS) have fallen to Rs -18.09, reflecting a decrease in profitability and lower earnings for shareholders.

For more insights on Albert David's financial trend performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News